REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 89 filers reported holding REGULUS THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $3,000 | -70.0% | 16,076 | +7.1% | 0.00% | – |
| Q2 2018 | $10,000 | -47.4% | 15,004 | -18.3% | 0.00% | – |
| Q4 2017 | $19,000 | – | 18,369 | +5500.3% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 328 | -99.0% | 0.00% | – |
| Q2 2017 | $31,000 | -49.2% | 31,324 | -15.8% | 0.00% | – |
| Q1 2017 | $61,000 | -21.8% | 37,193 | +6.9% | 0.00% | – |
| Q4 2016 | $78,000 | -9.3% | 34,793 | +32.9% | 0.00% | – |
| Q3 2016 | $86,000 | -6.5% | 26,173 | -19.0% | 0.00% | – |
| Q2 2016 | $92,000 | -57.0% | 32,296 | +4.4% | 0.00% | – |
| Q1 2016 | $214,000 | +68.5% | 30,930 | +112.0% | 0.00% | – |
| Q4 2015 | $127,000 | +98.4% | 14,591 | +50.8% | 0.00% | – |
| Q3 2015 | $64,000 | -27.3% | 9,673 | +19.8% | 0.00% | – |
| Q2 2015 | $88,000 | -26.1% | 8,072 | +15.8% | 0.00% | – |
| Q1 2015 | $119,000 | -91.9% | 6,972 | -92.4% | 0.00% | -100.0% |
| Q4 2014 | $1,468,000 | – | 91,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,039,823 | $26,420,000 | 3.79% |
| Foresite Capital Management II, LLC | 1,750,269 | $11,447,000 | 3.48% |
| ARGONAUT CAPITAL MANAGEMENT CORP | 75,000 | $491,000 | 1.65% |
| Abingworth LLP | 327,350 | $2,138,000 | 1.25% |
| Trellus Management Company, LLC | 100,000 | $654,000 | 0.96% |
| Cormorant Asset Management, LP | 896,522 | $5,863,000 | 0.94% |
| DAFNA Capital Management LLC | 90,000 | $589,000 | 0.58% |
| ORACLE INVESTMENT MANAGEMENT INC | 749,064 | $4,898,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |